Search Results

Drug Development

Sysmex Inostics’ RAS-RAF-SEQ Assay Receives New York State Department of Health CLEP Approval for Use in Clinical Trials

September 17, 2024

·

3 min read

Business

Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development

Sysmex Inostics Inc. and Genomic Testing Cooperative (GTC) formed a strategic partnership for Sysmex Inostics to commercialize GTC’s tissue and liquid biopsy solid tumors and hematology assay services to biopharma customers.

April 13, 2023

·

4 min read

BioCapital

Sysmex Inostics Opens Cancer Research Excellence Program for Submissions

Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, has opened submissions for its Cancer Research Excellence Program (CREP).

February 14, 2023

·

4 min read

BioCapital

Sysmex Inostics Exhibits at American Association for Cancer Research Annual Meeting 2023 in Orlando

Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, is exhibiting at the American Association for Cancer Research® (AACR) Annual Meeting 2023 in Orlando, FL from April 16, 2023, through April 19, 2023.

April 17, 2023

·

4 min read

BioMidwest

Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States

Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.

April 2, 2024

·

2 min read

BioCapital

Sysmex Inostics Exhibits at Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoenix Arizona

Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, will exhibit at the Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoenix Arizona from November 3, 2022, through November 5, 2022.

November 1, 2022

·

4 min read

Business

Sysmex America Announces Dan Zortman as New CEO

July 10, 2024

·

2 min read

BioCapital

Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022

Sysmex Inostics, Inc. and QIAGEN N.V. will co-exhibit at the 2022 ASCO Annual Meeting, the world’s largest clinical cancer research meeting, held June 3, 2022, through June 7, 2022, in Chicago.

June 2, 2022

·

4 min read

BioCapital

Sysmex Inostics Expands Blood Test Offerings for Detection of Acute Myeloid Leukemia

Sysmex Inostics has expanded its offering of CLIA-validated tests to include AML-SEQ™, a focused panel to detect mutations of the three most prevalent genes found in Acute Myeloid Leukemia – IDH1/2 & NPM1.

May 24, 2022

·

4 min read

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies.

December 14, 2023

·

3 min read